ABBOTT LABORATORIES - Common Stock (ABT)

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / Common Stock
Shares outstanding
1,740,239,592
Number of holders
1,458
Total 13F shares, excl. options
1,027,156,427
Shares change
-13,854,046
Total reported value, excl. options
$47,581,322,011
Value change
-$627,926,143
Put/Call ratio
78%
Number of buys
560
Number of sells
-687
Price
$46.33

Significant Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q1 2015

1,575 filings reported holding ABT - ABBOTT LABORATORIES - Common Stock as of Q1 2015.
ABBOTT LABORATORIES - Common Stock (ABT) has 1,458 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,027,156,427 shares of 1,740,239,592 outstanding shares and own 59.02% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (90,359,272 shares), STATE STREET CORP (65,042,595 shares), BlackRock Institutional Trust Company, N.A. (40,427,968 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (33,362,223 shares), Bank of New York Mellon Corp (30,844,787 shares), NORTHERN TRUST CORP (23,855,856 shares), JENNISON ASSOCIATES LLC (21,571,193 shares), BlackRock Fund Advisors (20,105,898 shares), JPMORGAN CHASE & CO (19,970,566 shares), and PRIMECAP MANAGEMENT CO/CA/ (17,765,299 shares).
This table shows the top 1458 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.